A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Pfizer
Obsidian Therapeutics, Inc.
Filamon LTD
Ankyra Therapeutics, Inc
Elephas
Novartis
Elephas
Massive Bio, Inc.
Delfi Diagnostics Inc.
Medicenna Therapeutics, Inc.
DEKA Biosciences
Tempus AI
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Taproot Health
Iovance Biotherapeutics, Inc.
VitaMed Research LLC
Sanguine Biosciences
Klus Pharma Inc.
Revolution Medicines, Inc.
Bristol-Myers Squibb
Revolution Medicines, Inc.
BioNTech SE
SpeciCare
Lumos Pharma
Celgene
Santa Maria Biotherapeutics
BIND Therapeutics
Calando Pharmaceuticals
NS Pharma, Inc.